DKK1 and pancreatic ductal adenocarcinoma: Patients with HNSCC, LUAD, BRCA, KIRP, pancreatic ductal adenocarcinoma (PAAD), LIHC, and STAD who had high DKK1 levels had shorter survival times (Figure 2A–2G).